Ginkgo Bioworks (DNA) Q1 2024 Earnings
DNA·Reported May 9, 2024·After market close
Ginkgo Bioworks reported Q1 2024 revenue of $37.9M, missed analyst consensus of $43.7M by $5.8M. Diluted EPS came in at $-3.20.
Revenue
$37.9Mmissed by $5.8M
Consensus: $43.7MDiluted EPS
$-3.20met estimate
Consensus: $-3.20
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Ginkgo Bioworks's Q1 2024 earnings report.
Ginkgo Bioworks (DNA) reported Q1 2024 earnings on May 9, 2024 after market close.
Ginkgo Bioworks reported revenue of $37.9M and diluted EPS of $-3.20 for Q1 2024.
Revenue missed the consensus estimate of $43.7M by $5.8M. EPS beat the consensus estimate of $-3.20 by $0.00.
You can read the 10-Q periodic report (0001628280-24-022229) directly on SEC EDGAR. The filing index links above go to sec.gov.